{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:12:11Z","timestamp":1789056731198,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025\\u201300559450"],"award-info":[{"award-number":["RS-2025\\u201300559450"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00210807"],"award-info":[{"award-number":["RS-2023-00210807"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002641","name":"Konkuk University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22213MFDS393"],"award-info":[{"award-number":["22213MFDS393"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152756","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T07:50:38Z","timestamp":1759391438000},"page":"152756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dual-cardiotoxicity evaluation of torsadogenic risk drugs using human iPSC-derived cardiomyocytes"],"prefix":"10.1016","volume":"786","author":[{"given":"Seul-Gi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinhye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-3736","authenticated-orcid":false,"given":"Jin","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonseo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeonghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Min","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152756_bib1","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehy365","article-title":"Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications","volume":"40","author":"Ferdinandy","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2025.152756_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.adg6276","article-title":"FDA no longer has to require animal testing for new drugs","volume":"379","author":"Wadman","year":"2023","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbrc.2025.152756_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/aor.14503","article-title":"FDA modernization act 2.0 allows for alternatives to animal testing","volume":"47","author":"Han","year":"2023","journal-title":"Artif. Organs"},{"key":"10.1016\/j.bbrc.2025.152756_bib4","first-page":"223","article-title":"Alternatives to animal testing: a review","volume":"23","author":"Doke","year":"2015","journal-title":"Saudi Pharm. J. : SPJ : the official publication of the Saudi Pharmaceutical Society"},{"key":"10.1016\/j.bbrc.2025.152756_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yrtph.2019.03.016","article-title":"Use of stem cells as alternative methods to animal experimentation in predictive toxicology","volume":"105","author":"Kim","year":"2019","journal-title":"Regul. Toxicol. Pharmacol. : RTP (Regul. Toxicol. Pharmacol.)"},{"key":"10.1016\/j.bbrc.2025.152756_bib6","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddy186","article-title":"Drug screening for human genetic diseases using iPSC models","volume":"27","author":"Elitt","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2025.152756_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5966\/sctm.2013-0162","article-title":"Concise review: drug discovery in the age of the induced pluripotent stem cell","volume":"3","author":"Ko","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bbrc.2025.152756_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes","volume":"117","author":"Karakikes","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152756_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bbrc.2025.152756_bib10","doi-asserted-by":"crossref","DOI":"10.1063\/1.5132618","article-title":"In silico models for evaluating proarrhythmic risk of drugs","volume":"4","author":"Hwang","year":"2020","journal-title":"APL Bioeng."},{"key":"10.1016\/j.bbrc.2025.152756_bib11","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2025.152756_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbrc.2025.152756_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0091270006286436","article-title":"Clinical evaluation of QT\/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use E14 guideline","volume":"46","author":"Darpo","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152756_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pharmthera.2010.08.008","article-title":"An evaluation of hERG current assay performance: translating preclinical safety studies to clinical QT prolongation","volume":"129","author":"Gintant","year":"2011","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrc.2025.152756_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/toxsci\/kft205","article-title":"Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model","volume":"136","author":"Guo","year":"2013","journal-title":"Toxicol. Sci. : an official journal of the Society of Toxicology"},{"key":"10.1016\/j.bbrc.2025.152756_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pharmthera.2014.03.004","article-title":"Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing","volume":"143","author":"Sinnecker","year":"2014","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrc.2025.152756_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2021.03.039","article-title":"Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes\/multielectrode assay platform","volume":"555","author":"Lee","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.152756_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ehjcvp\/pvz038","article-title":"Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries","volume":"6","author":"Eroglu","year":"2020","journal-title":"European heart journal. Cardiovascular pharmacotherapy"},{"key":"10.1016\/j.bbrc.2025.152756_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000329966","article-title":"The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in Guinea pig isolated hearts","volume":"27","author":"Guo","year":"2011","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.bbrc.2025.152756_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-8703(05)80018-3","article-title":"Negative inotropic effect of intravenous nifedipine in coronary artery disease: relation to plasma levels","volume":"119","author":"Clifton","year":"1990","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbrc.2025.152756_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/19768354.2018.1451367","article-title":"Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts","volume":"22","author":"Bang","year":"2018","journal-title":"Anim. Cell Syst."},{"key":"10.1016\/j.bbrc.2025.152756_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116108","article-title":"Evaluation of the cardiotoxicity potential of bisphenol analogues in human induced pluripotent stem cells derived cardiomyocytes","volume":"272","author":"Lee","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bbrc.2025.152756_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/toxsci\/kfae015","article-title":"Comparative cardiotoxicity assessment of bisphenol chemicals and estradiol using human induced pluripotent stem cell-derived cardiomyocytes","volume":"198","author":"Cooper","year":"2024","journal-title":"Toxicol. Sci. : an official journal of the Society of Toxicology"},{"key":"10.1016\/j.bbrc.2025.152756_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118196","article-title":"Evaluation of phthalates induced cardiotoxicity using human iPSCs-derived cardiomyocyte and dual-cardiotoxicity evaluation methods","volume":"296","author":"Lee","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bbrc.2025.152756_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/toxsci\/kfy110","article-title":"Cross-site reliability of human induced pluripotent stem cell-derived cardiomyocyte based safety assays using microelectrode arrays: results from a blinded CiPA pilot study","volume":"164","author":"Millard","year":"2018","journal-title":"Toxicol. Sci. : an official journal of the Society of Toxicology"},{"key":"10.1016\/j.bbrc.2025.152756_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/mol.110.069492","article-title":"Verapamil block of T-type calcium channels","volume":"79","author":"Bergson","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152756_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1124\/mol.119.117531","article-title":"Structural basis for diltiazem block of a voltage-gated Ca(2+) channel","volume":"96","author":"Tang","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152756_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7603\/s40681-014-0024-z","article-title":"New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker","volume":"4","author":"Chou","year":"2014","journal-title":"Biomedicine"},{"key":"10.1016\/j.bbrc.2025.152756_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.152756_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro proarrhythmia assay (CiPA) initiative - update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bbrc.2025.152756_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2025.152756_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tcm.2017.07.010","article-title":"CredibleMeds.org: what does it offer?","volume":"28","author":"Woosley","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2025.152756_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41378-021-00344-0","article-title":"Microengineered platforms for characterizing the contractile function of in vitro cardiac models","volume":"8","author":"Dou","year":"2022","journal-title":"Microsystems & nanoengineering"},{"key":"10.1016\/j.bbrc.2025.152756_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/ten.tec.2014.0283","article-title":"Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales","volume":"21","author":"Huebsch","year":"2015","journal-title":"Tissue Eng. C Methods"},{"key":"10.1016\/j.bbrc.2025.152756_bib35","doi-asserted-by":"crossref","DOI":"10.1113\/JP287275","article-title":"Determining properties of human-induced pluripotent stem cell-derived cardiomyocytes using spatially resolved electromechanical metrics","author":"J\u00e6ger","year":"2025","journal-title":"The Journal of physiology"},{"key":"10.1016\/j.bbrc.2025.152756_bib36","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.3390\/cimb46070377","article-title":"The evolving role of calcium channel blockers in hypertension management: pharmacological and clinical considerations","volume":"46","author":"Jones","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbrc.2025.152756_bib37","article-title":"Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: implications for disease modeling and maturation","volume":"10","author":"Ernst","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.152756_bib38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/stcltm\/szae029","article-title":"Promotion of maturation of human pluripotent stem cell-derived cardiomyocytes via treatment with the peroxisome proliferator-activated receptor alpha agonist fenofibrate","volume":"13","author":"Lee","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bbrc.2025.152756_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121860","article-title":"Generation of human iPSCs derived heart organoids structurally and functionally similar to heart","volume":"290","author":"Lee","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152756_bib40","article-title":"Modeling heart rhythm using human engineered heart tissues","author":"Tu","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2025.152756_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.stem.2022.03.012","article-title":"Progress in multicellular human cardiac organoids for clinical applications","volume":"29","author":"Kim","year":"2022","journal-title":"Cell Stem Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501472X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501472X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:10:25Z","timestamp":1773133825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2501472X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0006291X2501472X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152756","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-cardiotoxicity evaluation of torsadogenic risk drugs using human iPSC-derived cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152756"}}